News

LifeMD Under Fire: Investors Face Challenges Amid Lawsuit

LifeMD Under Fire: Investors Face Challenges Amid Lawsuit

LifeMD Faces a Lawsuit Over Financial Misstatements

Recently, a federal securities fraud class action lawsuit has emerged against LifeMD (NASDAQ: LFMD). This telehealth company is alleged to have misled investors regarding its financial condition and future growth opportunities. The lawsuit was initiated in the Eastern District of New York after a noticeable decline in the company’s stock price following its earnings announcement.

Class Action Overview and Key Dates

Investors in LifeMD who have experienced significant financial losses should be aware of important deadlines associated with the lawsuit. The class period is defined from May 7, 2025, to August 5, 2025, while the lead plaintiff deadline is set for October 27, 2025. If you believe you qualify, it is crucial to act quickly.

Understanding the Allegations

The lawsuit, specifically titled Johnston v. LifeMD, Inc., focuses on accusations that the company made unfairly optimistic statements about its first-quarter results reported on May 6, 2025. During this announcement, LifeMD raised its revenue forecasts and EBITDA guidance, claiming advantages in the competitive market of virtual obesity care and highlighting the success of its RexMD brand.

The True Nature of LifeMD’s Operations

However, the lawsuit claims that LifeMD failed to disclose several pressing challenges impacting their operations. The company was reportedly facing rising costs to acquire customers in its RexMD segment and an unexpectedly high refund rate in its weight management offerings. These issues were not communicated to investors, leading to deception in stock value.

The Stock Price Decline

On August 5, 2025, the situation deteriorated when LifeMD released its second-quarter results, which missed both revenue and earnings estimates. The management team attributed this underperformance to "temporary elevated customer acquisition costs" and negative impacts from patient refund rates. As a result, LifeMD's stock plummeted by more than 44% the following day, leaving many investors in shock.

What This Means for Investors

The ongoing lawsuit serves as a crucial opportunity for investors harmed during this tumultuous period to seek recovery of their losses. It highlights the risks associated with investments in companies that fail to maintain transparency in their operations and financial outlooks.

Investigation by Hagens Berman

Hagens Berman, a national plaintiffs' rights firm, is taking the lead in investigating these claims against LifeMD. The firm is probing whether the company was aware of critical operational issues yet chose not to disclose them to investors. Reed Kathrein, a partner at Hagens Berman, stated that this investigation aims to uncover the truth behind LifeMD's statements and operational practices.

Opportunity for Whistleblowers

People with non-public information regarding LifeMD’s practices may be able to contribute to this investigation. There are even incentives for whistleblowers under the SEC Whistleblower program, which rewards those who provide original information that leads to successful recovery efforts.

Getting in Touch with Hagens Berman

If you have pertinent information or suffered losses due to your investment in LifeMD, reaching out to Hagens Berman could provide valuable resources. They have set up approachable lines of communication through phone and email to assist potential claimants with their inquiries.

Frequently Asked Questions

What is the basis for the lawsuit against LifeMD?

The lawsuit alleges that LifeMD provided misleading information regarding its financial health and growth expectations, which contributed to a sharp decline in stock prices.

Who can participate in the class action?

Investors who experienced significant financial losses during the defined class period from May 7 to August 5, 2025, can participate in the class action.

What are the key dates related to the lawsuit?

The class period is from May 7, 2025, to August 5, 2025, with a lead plaintiff deadline of October 27, 2025.

How will this lawsuit impact LifeMD?

The outcome could significantly affect the company’s reputation and financial standing, while also providing recovery opportunities for affected investors.

Where can I find more information about Hagens Berman's investigation?

More information can be acquired by reaching out via their website or contact details provided for investors affected by the case.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lithium's Next Leg Depends on Storage, Not EV Hype

Updated Category News Views 67

Grid batteries are quietly becoming lithium’s second engine, and that matters more than another flashy electric-vehicle sales headline. The market is projected to rise from $40.87 billion in 2026 to $57.77 billion by 2031, a 7.2% compound annual growth rate. Respectable growth, certainly. But this is not a straight line, and anybody treating a five-year market forecast...

Continue Reading
Travelzoo Turns Thanksgiving Delays Into Member Value

Updated Category News Views 82

Airport gridlock is a miserable place to make a membership pitch, yet Travelzoo has found a pretty shrewd angle for it. On November 18, the company said nearly 20 million travelers will move through airports during the upcoming Thanksgiving holiday, when cancellations and delays can turn an ordinary trip into a long, fluorescent-lit slog. Its offer: qualifying Club...

Continue Reading
CATL Makes Its APEC Case Beyond the Electric Car Market

Updated Category News Views 63

A 99-Second Pitch With Bigger Ambitions Battery swapping got a rare moment in the geopolitical sunlight at Shenzhen's APEC CEO Summit, and CATL was plainly trying to make that moment count. Dr. Robin Zeng, the company's founder, chairman and chief executive, used the opening business dialogue to argue that the Asia-Pacific region holds more opportunity than trouble. Fair...

Continue Reading
Nellie's 50% Booking Jump Reveals a Quieter Luxury

Updated Category News Views 83

Silicon Valley’s rich are apparently tired of performing wealth for strangers, and frankly, that tracks. Nellie’s 2027 forecast says its mostly tech-money clientele is moving past the old trophy case of private jets, famous resort towns, and suites priced like small houses. The prize now is privacy, a clean schedule, and somebody competent fixing the ugly little...

Continue Reading
A Parish Memoir That Sends Its Proceeds Back Home

Updated Category News Views 94

Some books arrive with a thunderclap; this one shows up carrying a folding chair, a prayer book, and a memory that refuses to leave. You Give Them Something to Eat, the new memoir from Fr. Michael J Rieder, is built from more than a hundred short chapters rather than one grand, polished life story. That choice fits the material. Parish life is rarely a clean parade of...

Continue Reading
Haemonetics Opens Europe for VASCADE MVP XL Device

Updated Category News Views 87

A larger collagen plug is hardly cocktail-party material, yet it can matter a great deal when it sits inside a procedure workflow hospitals are trying to speed up. Haemonetics has received CE Mark certification under the EU Medical Device Regulation for VASCADE MVP XL, its larger-bore venous vascular closure system, and first commercial European procedures were completed...

Continue Reading
IIT Madras Maps 100 Brains in a Serious Science Bet

Updated Category News Views 40

A human brain turned into a navigable cellular map is not a flashy launch-day trinket. It is painstaking infrastructure, the kind that can sit quietly for years before researchers figure out what it truly unlocks. That is why the Sudha Gopalakrishnan Brain Centre mission at IIT Madras deserves a serious look rather than the usual chest-thumping over a big scientific...

Continue Reading
BetterInvesting Puts ELMD and FIVE Under a Fresh Lens

Updated Category News Views 30

Two familiar market traps are hiding in this otherwise useful announcement: mistaking a study candidate for a buy signal, and treating the word undervalued like it fell from a mountaintop. BetterInvesting has named Electromed Inc. as its “Stock to Study” and Five Below Inc. as its “Undervalued Stock” for the January-February 2027 issue of its magazine. That is...

Continue Reading
Mar-Jac's Safety Milestone Carries Real Operational Weight

Updated Category News Views 16

Four million worked hours without a lost-time accident is the sort of number that ought to make people pause, especially in poultry processing. Mar-Jac Poultry’s Gainesville facility earned Workplace Safety recognition from the Greater Hall Chamber of Commerce after reaching that mark, and this is one corporate achievement that deserves a little less eye-rolling than...

Continue Reading
Italian Wine Faces U.S. Slump and New Market Openings

Updated Category News Views 110

American demand has put a cork in the easy story, and Italian wine producers cannot pretend otherwise. In the first nine months of 2026, U.S. imports of Italian wine dropped 18.4% by value. That is painful because the United States remains Italy's largest destination market by value, not some side shelf that can be ignored until conditions improve. Still, the broader U.S....

Continue Reading

Top 5 Most Recently Viewed Articles

Big Lots Adjusts Strategy Amid Bankruptcy Process Challenges

Updated Category News Views 183

Big Lots Updates on Court-Supervised Process No Longer Anticipates Closing Previously Announced Sale to Nexus Capital Management Continues Efforts Towards a Going Concern Transaction Gearing Up for Going Out of Business Sales at Remaining Locations Big Lots, Inc. has recently made crucial updates regarding its financial restructuring efforts. The company has announced...

Continue Reading
Detailed Overview of Man Group PLC's Stake in American Axle

Updated Category News Views 133

Key Information About Man Group PLC's Disclosures FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE This document represents a disclosure by a person with interests in relevant securities, specifically when owning 1% or more of American Axle & Manufacturing Holdings, Inc. As per Rule 8.3 of the Takeover Code, certain details regarding the interests and...

Continue Reading
Westlake Chemical Gets Boost from Analysts with New Targets

Updated Category News Views 67

Westlake Chemical Upgraded to Neutral Recently, BofA Securities made a notable adjustment regarding Westlake Chemical (NASDAQ: WLK), changing the stock's rating from Underperform to Neutral. This upgrade included raising the price target to $159 from $151, reflecting a more balanced view on the company's trajectory. The changes stem from a reassessment that weighs current...

Continue Reading
Envision Energy Recognized Among Leading Climate Tech Innovators

Updated Category News Views 209

Envision Energy's Recognition in Climate Technology Envision Energy has earned a well-deserved place on a prestigious list recognizing transformative companies in climate technology. This acknowledgment highlights their significant contributions in the fight against climate change through innovative renewable energy solutions. A Global Leader in Renewable Energy Known for...

Continue Reading
Exploring Franco-Nevada's Ten-Year Investment Journey

Updated Category News Views 155

Understanding Franco-Nevada's Investment Growth Franco-Nevada (NYSE: FNV) has showcased impressive performance over the last decade, delivering an average annual return of 14.64%. With a market capitalization of $30.52 billion, it has consistently outperformed the overall market by 3.21% on an annualized basis. The Impact of Compounding Returns Let's say an investor...

Continue Reading